Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease

Neuroscience

Volumn 160, Issue 2, 2009, Pages 427-433

  Thangavel, R ^b   Sahu, S K ^b   Van Hoesen, G W ^b   Zaheer, A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Alzheimer's disease; entorhinal cortex; hyperphosphorylated tau protein; neurofibrillary tangles; nonphosphorylated neurofilament protein; perirhinal cortex

Indexed keywords

NEUROFILAMENT PROTEIN; PROTEIN SMI32; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES; NEUROFILAMENT PROTEINS; NEURONS; PHOSPHORYLATION; PYRAMIDAL CELLS; REFERENCE VALUES; TAU PROTEINS; TEMPORAL LOBE; TISSUE DISTRIBUTION;

EID: 64049108878     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.02.037     Document Type: Article

References (37)

1. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., and Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1 (1991) 103-116
2. Arnold S.E., Hyman B.T., Van Hoesen G.W., and Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48 (1991) 625-632
3. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., and Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42 (1992) 631-639
4. Augustinack J.C., Schneider A., Mandelkow E.M., and Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103 (2002) 26-35
5. Ayala-Grosso C., Tam J., Roy S., Xanthoudakis S., Da Costa D., Nicholson D.W., and Robertson G.S. Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease. Neuroscience 141 (2006) 863-874
6. Bierer L.M., Hof P.R., Purohit D.P., Carlin L., Schmeidler J., Davis K.L., and Perl D.P. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 52 (1995) 81-88
7. Bobinski M., Wegiel J., Tarnawski M., Bobinski M., Reisberg B., de Leon M.J., Miller D.C., and Wisniewski H.M. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56 (1997) 414-420
8. Bouras C., Hof P.R., and Morrison J.H. Neurofibrillary tangle densities in the hippocampal formation in a nondemented population define subgroups of patients with differential early pathologic changes. Neurosci Lett 153 (1993) 131-135
9. Bussiere T., Giannakopoulos P., Bouras C., Perl D.P., Morrison J.H., and Hof P.R. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J Comp Neurol 463 (2003) 281-302
10. Bussiere T., Gold G., Kovari E., Giannakopoulos P., Bouras C., Perl D.P., Morrison J.H., and Hof P.R. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience 117 (2003) 577-592
11. Campbell M.J., and Morrison J.H. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neurol 282 (1989) 191-205
12. Duong T., and Gallagher K.A. Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer disease. Mol Chem Neuropathol 22 (1994) 105-122
13. Elston G.N., and Rosa M.G. The occipitoparietal pathway of the macaque monkey: comparison of pyramidal cell morphology in layer III of functionally related cortical visual areas. Cereb Cortex 7 (1997) 432-452
14. Fukutani Y., Cairns N.J., Shiozawa M., Sasaki K., Sudo S., Isaki K., and Lantos P.L. Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. Psychiatry Clin Neurosci 54 (2000) 523-529
15. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., Morrison J.H., Gold G., and Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60 (2003) 1495-1500
16. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., and Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41 (1997) 17-24
17. Gomez-Isla T., Price J.L., McKeel Jr. D.W., Morris J.C., Growdon J.H., and Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16 (1996) 4491-4500
18. Guillozet A.L., Weintraub S., Mash D.C., and Mesulam M.M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 60 (2003) 729-736
19. Hof P.R., Cox K., and Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol 301 (1990) 44-54
20. Hof P.R., and Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J Comp Neurol 301 (1990) 55-64
21. Hof P.R., and Morrison J.H. Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: a quantitative immunohistochemical analysis. J Comp Neurol 352 (1995) 161-186
22. Hof P.R., Rosenthal R.E., and Fiskum G. Distribution of neurofilament protein and calcium-binding proteins parvalbumin, calbindin, and calretinin in the canine hippocampus. J Chem Neuroanatomy 11 (1996) 1-12
23. Hof P.R., Ungerleider L.G., Webster M.J., Gattass R., Adams M.M., Sailstad C.A., and Morrison J.H. Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways. J Comp Neurol 376 (1996) 112-127
24. Law A.J., and Harrison P.J. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. J Psychiatr Res 37 (2003) 487-499
25. Lewis D.A., Campbell M.J., Terry R.D., and Morrison J.H. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 7 (1987) 1799-1808
26. Macdonald V., and Halliday G. Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol Dis 10 (2002) 378-386
27. Mitchell T.W., Mufson E.J., Schneider J.A., Cochran E.J., Nissanov J., Han L.Y., Bienias J.L., Lee V.M., Trojanowski J.Q., Bennett D.A., and Arnold S.E. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol 51 (2002) 182-189
28. Morrison J.H., and Hof P.R. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res 136 (2002) 467-486
29. Morrison J.H., Lewis D.A., Campbell M.J., Huntley G.W., Benson D.L., and Bouras C. A monoclonal antibody to nonphosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res 416 (1987) 331-336
30. Radenahmad N., Neal J.W., Wilcock G., and Pearson R.C. A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease. Neuropathol Appl Neurobiol 29 (2003) 316-320
31. Shepherd C.E., Thiel E., McCann H., and Halliday G.M. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease. Neurobiol Dis 8 (2001) 136-146
32. Sieradzan K.A., and Mann D.M. The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol 27 (2001) 1-21
33. Su J.H., Cummings B.J., and Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res 739 (1996) 79-87
34. Thangavel R., Sahu S.K., Van Hoesen G.W., and Zaheer A. Modular and laminar pathology of brodmann's area 37 in Alzheimer's disease. Neuroscience 152 (2008) 50-55
35. Thangavel R., Van Hoesen G.W., and Zaheer A. The abnormally phosphorylated tau lesion of early Alzheimer's disease. Neurochem Res 34 (2009) 118-123
36. Vickers J.C., Riederer B.M., Marugg R.A., Buee-Scherrer V., Buee L., Delacourte A., and Morrison J.H. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 62 (1994) 1-13
37. Wakabayashi K., Hansen L.A., and Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with antiubiquitin and SMI32. Acta Neuropathol 89 (1995) 404-408